Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy VP, Sales and Marketing bought 2,000 shares at an average $2.33 ($4,651)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy VP, Sales and Marketing bought 10,000 shares at an average $3.18 ($31,750)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Former Director acquired 11,500 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 15,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 36,000 shares (grant or award)
  15. 4 Grant or award Director acquired 35,000 shares (grant or award)
  16. 4 Grant or award Director acquired 34,000 shares (grant or award)
  17. 4 Grant or award Director acquired 38,000 shares (grant or award)
  18. 4 Grant or award Director acquired 39,500 shares (grant or award)
  19. 4 Grant or award Director acquired 15,000 shares (grant or award)
  20. 4/A Derivatives Options or other derivatives

Page 19 of 28 · 551 filings